ACM
ZYME icon

Aster Capital Management’s Zymeworks ZYME Stock Holding History

Aster Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42
Closed -$500 – 1303
2026
Q1 		$500 Buy
+42
New +$994 ﹤0.01% 795
2025
Q2 		– Sell
-217
Closed -$2.91K – 1652
2025
Q1 		$2.91K Buy
217
+147
+210% +$2K ﹤0.01% 1158
2024
Q4 		$1.02K Sell
70
-686
-91% -$9.59K ﹤0.01% 1009
2024
Q3 		$9.49K Buy
+756
New +$8.23K ﹤0.01% 820

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Aster Capital Management's ZYME Position: Q2 2026 in Review

Aster Capital Management sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 42 shares — an estimated $500 sold.

Aster Capital Management first reported a position in ZYME in Q3 2024 and held it in 4 quarters. The position peaked at $9.49K in Q3 2024. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Aster Capital Management reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 42 Zymeworks shares in Q2 2026, an estimated $500.
  • Aster Capital Management first reported a position in Zymeworks in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's Zymeworks position peaked at $9.49K in Q3 2024.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.